Merger of drugmakers Valeant, Actavis on hold -source
April 27 (Reuters) - Talks are on hold to merge drugmakers Valeant Pharmaceuticals International Inc and Actavis Inc in a deal that would have created a healthcare giant, a person familiar with the situation told Reuters on Saturday.
A Valeant spokeswoman and an Actavis spokesman could not be immediately reached for comment outside of business hours.
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video